208 related articles for article (PubMed ID: 11717443)
1. Vaccination, prevention, and treatment of experimental autoimmune neuritis (EAN) by an oligomerized T cell epitope.
Stienekemeier M; Falk K; Rötzschke O; Weishaupt A; Schneider C; Toyka KV; Gold R; Strominger JL
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13872-7. PubMed ID: 11717443
[TBL] [Abstract][Full Text] [Related]
2. Prevention of experimental autoimmune neuritis by nasal administration of P2 protein peptide 57-81.
Zhu J; Deng GM; Levi M; Wahren B; Diab A; van der Meide PH; Link H
J Neuropathol Exp Neurol; 1998 Mar; 57(3):291-301. PubMed ID: 9600221
[TBL] [Abstract][Full Text] [Related]
3. Induction of experimental allergic neuritis in the BN rat: P2 protein-specific T cells overcome resistance to actively induced disease.
Linington C; Mann A; Izumo S; Uyemura K; Suzuki M; Meyermann R; Wekerle H
J Immunol; 1986 Dec; 137(12):3826-31. PubMed ID: 2431045
[TBL] [Abstract][Full Text] [Related]
4. Induction of peripheral tolerance with peptide-specific anergy in experimental autoimmune neuritis.
Gregorian SK; Clark L; Heber-Katz E; Amento EP; Rostami A
Cell Immunol; 1993 Sep; 150(2):298-310. PubMed ID: 7690307
[TBL] [Abstract][Full Text] [Related]
5. A complementary peptide vaccine that induces T cell anergy and prevents experimental allergic neuritis in Lewis rats.
Araga S; Kishimoto M; Doi S; Nakashima K
J Immunol; 1999 Jul; 163(1):476-82. PubMed ID: 10384151
[TBL] [Abstract][Full Text] [Related]
6. Prevention and therapy of experimental autoimmune neuritis by an antibody against T cell receptors-alpha/beta.
Jung S; Krämer S; Schluesener HJ; Hünig T; Toyka K; Hartung HP
J Immunol; 1992 Jun; 148(12):3768-75. PubMed ID: 1376340
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1.
Archelos JJ; Mäurer M; Jung S; Miyasaka M; Tamatani T; Toyka KV; Hartung HP
Lab Invest; 1994 May; 70(5):667-75. PubMed ID: 8196363
[TBL] [Abstract][Full Text] [Related]
8. Treatment and prevention of experimental autoimmune neuritis with superagonistic CD28-specific monoclonal antibodies.
Schmidt J; Elflein K; Stienekemeier M; Rodriguez-Palmero M; Schneider C; Toyka KV; Gold R; Hünig T
J Neuroimmunol; 2003 Jul; 140(1-2):143-52. PubMed ID: 12864982
[TBL] [Abstract][Full Text] [Related]
9. T cell vaccination does not induce resistance to experimental autoimmune neuritis.
Jung S; Schluesener HJ; Toyka K; Hartung HP
J Neuroimmunol; 1991 Dec; 35(1-3):1-11. PubMed ID: 1720130
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effect of transforming growth factor-beta 2 on actively induced EAN but not adoptive transfer EAN.
Jung S; Schluesener HJ; Schmidt B; Fontana A; Toyka KV; Hartung HP
Immunology; 1994 Dec; 83(4):545-51. PubMed ID: 7533133
[TBL] [Abstract][Full Text] [Related]
11. Peptide 53-78 of myelin P2 protein is a T cell epitope for the induction of experimental autoimmune neuritis.
Rostami A; Gregorian SK
Cell Immunol; 1991 Feb; 132(2):433-41. PubMed ID: 1703049
[TBL] [Abstract][Full Text] [Related]
12. Modulation of experimental autoimmune neuritis in Lewis rats by oral application of myelin antigens.
Gaupp S; Hartung HP; Toyka K; Jung S
J Neuroimmunol; 1997 Nov; 79(2):129-37. PubMed ID: 9394785
[TBL] [Abstract][Full Text] [Related]
13. Transfer of myelin-specific cells deviated in vitro towards IL-4 production ameliorates ongoing experimental allergic neuritis.
Ekerfelt C; Dahle C; Weissert R; Kvarnström M; Olsson T; Ernerudh J
Clin Exp Immunol; 2001 Jan; 123(1):112-8. PubMed ID: 11168007
[TBL] [Abstract][Full Text] [Related]
14. Resistance and susceptibility to experimental autoimmune neuritis in Sprague-Dawley and Lewis rats correlate with different levels of autoreactive T and B cell responses to myelin antigens.
Zhu J; Zou LP; Bakhiet M; Mix E
J Neurosci Res; 1998 Nov; 54(3):373-81. PubMed ID: 9819142
[TBL] [Abstract][Full Text] [Related]
15. Treatment with P2 protein peptide 57-81 by nasal route is effective in Lewis rat experimental autoimmune neuritis.
Zou LP; Zhu J; Deng GM; Levi M; Wahren B; Diab A; Hillert J; Link H
J Neuroimmunol; 1998 May; 85(2):137-45. PubMed ID: 9630162
[TBL] [Abstract][Full Text] [Related]
16. Antigen therapy eliminates T cell inflammation by apoptosis: effective treatment of experimental autoimmune neuritis with recombinant myelin protein P2.
Weishaupt A; Gold R; Gaupp S; Giegerich G; Hartung HP; Toyka KV
Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1338-43. PubMed ID: 9037054
[TBL] [Abstract][Full Text] [Related]
17. Cell adhesion molecules of the immunoglobulin supergene family as tissue-specific autoantigens: induction of experimental allergic neuritis (EAN) by P0 protein-specific T cell lines.
Linington C; Lassmann H; Ozawa K; Kosin S; Mongan L
Eur J Immunol; 1992 Jul; 22(7):1813-7. PubMed ID: 1378018
[TBL] [Abstract][Full Text] [Related]
18. Trapped in the epineurium: early entry into the endoneurium is restricted to neuritogenic T cells in experimental autoimmune neuritis.
Mausberg AK; Szepanowski F; Odoardi F; Flügel A; Kleinschnitz C; Stettner M; Kieseier BC
J Neuroinflammation; 2018 Aug; 15(1):217. PubMed ID: 30068351
[TBL] [Abstract][Full Text] [Related]
19. Induction of severe experimental autoimmune neuritis with a synthetic peptide corresponding to the 53-78 amino acid sequence of the myelin P2 protein.
Rostami A; Gregorian SK; Brown MJ; Pleasure DE
J Neuroimmunol; 1990 Dec; 30(2-3):145-51. PubMed ID: 1699975
[TBL] [Abstract][Full Text] [Related]
20. Suppression of experimental allergic neuritis by an antibody to the intracellular adhesion molecule ICAM-1.
Archelos JJ; Mäurer M; Jung S; Toyka KV; Hartung HP
Brain; 1993 Oct; 116 ( Pt 5)():1043-58. PubMed ID: 7693297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
